Hyperleukocytotic secondary acute myeloid leukemia (AML) with sole monosomy 7 as sequela of Philadelphia-chromosome positive chronic myeloid leukemia (CML)

MeSH terms

• Aged
• Anemia, Refractory, with Excess of Blasts / etiology
• Anemia, Refractory, with Excess of Blasts / genetics
• Anemia, Refractory, with Excess of Blasts / pathology
• Antineoplastic Agents / therapeutic use
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use
• Benzamides
• Chromosome Deletion
• Chromosomes, Human, Pair 7*
• Cytarabine / administration & dosage
• Disease Progression
• Fatal Outcome
• Humans
• Imatinib Mesylate
• Interferon-alpha / administration & dosage
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics*
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
• Leukemia, Myeloid, Acute / etiology
• Leukemia, Myeloid, Acute / genetics*
• Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative / genetics
• Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative / pathology
• Leukocytosis / etiology*
• Male
• Monosomy*
• Philadelphia Chromosome
• Piperazines / therapeutic use
• Protein Kinase Inhibitors / therapeutic use
• Pyrimidines / therapeutic use
• Selection, Genetic